PBIGF trading today lower at $0, a decrease of -66.3158% from yesterday's close, completing a monthly decrease of -98.7888% or -$0.13. Over the past 12 months, PBIGF stock lost -99.3136%.
PBIGF is not paying dividends to its shareholders.
The last earnings report, released on Feb 26, 2025, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
Paradigm Biopharmaceuticals Limited has completed 1 stock splits, with the recent split occurring on Nov 01, 2023.
The company's stock is traded on 7 different exchanges and in various currencies, with the primary listing on ASX (AUD).